Filing Details
- Accession Number:
- 0001209191-23-054843
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-09 16:32:51
- Reporting Period:
- 2023-11-07
- Accepted Time:
- 2023-11-09 16:32:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1571949 | Intercontinental Exchange Inc. | ICE | Security & Commodity Brokers, Dealers, Exchanges & Services (6200) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1722067 | Benjamin Jackson | 5660 New Northside Drive Atlanta GA 30328 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-11-07 | 463 | $0.00 | 125,184 | No | 4 | G | Direct | |
Common Stock | Acquisiton | 2023-11-08 | 5,000 | $41.37 | 130,184 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-11-08 | 3,630 | $108.55 | 126,554 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-08 | 1,370 | $109.18 | 125,184 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | G | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2023-11-08 | 5,000 | $0.00 | 5,000 | $41.37 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,100 | 2024-01-17 | No | 4 | M | Direct |
Footnotes
- This transaction involved a gift of 463 shares of the issuer's common stock by the reporting person to a philanthropic organization.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022.
- The price range for the aggregate amount sold by the direct holder is $108.09 - $109.03. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- The price range for the aggregate amount sold by the direct holder is $109.10 - $109.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- The common stock number referred in Table I is an aggregate number and represents 111,910 shares of common stock and 13,274 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.
- The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
- These options are fully vested.